Caribou Biosciences, Inc. (CRBU) Retained Earnings (Accumulated Deficit) USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Caribou Biosciences, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2020 to 2024.
  • Caribou Biosciences, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$341 M, a 51.2% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$341 M -$115 M -51.2% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$299 M -$102 M -51.8% Dec 31, 2023 10-Q 2024-05-07
Q3 2023 -$265 M -$94.6 M -55.5% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$255 M -$111 M -77.4% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$225 M -$108 M -92.7% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 -$197 M -$99.4 M -102% Dec 31, 2022 10-K 2024-03-11
Q3 2022 -$170 M -$90.9 M -115% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 -$144 M -$85.2 M -146% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 -$117 M Mar 31, 2022 10-Q 2022-05-09
Q4 2021 -$97.8 M -$66.9 M -217% Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$79.3 M Sep 30, 2021 10-Q 2021-11-09
Q2 2021 -$58.3 M Jun 30, 2021 10-Q 2021-09-02
Q4 2020 -$30.9 M Dec 31, 2020 10-K 2022-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.